Discontinued — last reported Q3 '22
COVID-19 Testing Services — Net revenues
Quest Diagnostics COVID-19 Testing Services — Net revenues decreased by 11.0% to $316.00M in Q3 2022 compared to the prior quarter. Year-over-year, this metric declined by 55.4%, from $709.00M to $316.00M.
Analysis
How to read this metric
An increase indicates higher demand for pandemic-related testing, while a decrease reflects the transition of COVID-19 testing to endemic status or reduced public health testing requirements.
Detailed definition
This metric represents the total net revenue generated specifically from diagnostic testing services related to the SARS...
Peer comparison
Peers in the diagnostic and laboratory services sector report similar pandemic-related revenue streams, which are generally evaluated based on their contribution to total revenue and their sustainability as temporary versus recurring business.
dgx_segment_covid_19_testing_services_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | |
|---|---|---|---|---|---|---|
| Value | $511.00M | $709.00M | $722.00M | $599.00M | $355.00M | $316.00M |
| QoQ Change | — | +38.7% | +1.8% | -17.0% | -40.7% | -11.0% |
| YoY Change | — | — | — | — | -30.5% | -55.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Quest Diagnostics's covid-19 testing services — net revenues?
- Quest Diagnostics (DGX) reported covid-19 testing services — net revenues of $316.00M in Q3 2022.
- How has Quest Diagnostics's covid-19 testing services — net revenues changed year-over-year?
- Quest Diagnostics's covid-19 testing services — net revenues decreased by 55.4% year-over-year, from $709.00M to $316.00M.
- What does covid-19 testing services — net revenues mean?
- The total revenue earned from providing COVID-19 diagnostic and antibody testing services.